1. Medicare Part B drug payments: impact of price substitutions based on 2020 average sales prices Publication: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2022 Subject(s): Data AnalysisDrug CostsGovernment RegulationMedicare Part BUnited States
